27 Aug 2020 Governance

Leukaemia UK appoints new CEO

The trustees of Leukaemia UK are delighted to announce that they have appointed Fiona Hazell as CEO of Leukaemia UK. Fiona brings a strong track record in not-for-profit leadership, helping lead two mergers to create the UK’s largest breast cancer charity, as well as critical policy and campaigning successes, in her role as Director of Communications, Engagement & Influencing at Breast Cancer Now since 2014.

Chris Corbin OBE, Chairman of Leukaemia UK Trustees and a Director of Corbin & King, said:

“We are thrilled to welcome Fiona as our new CEO. Fiona brings a wealth of experience in the cancer charity sector and has outstanding leadership qualities. We are confident Fiona will lead Leukaemia UK to make an even more significant impact to those affected by leukaemia and other blood cancers. With blood cancer being the 5th most common type of cancer in the UK, it is essential that we continue to deliver on our objective to fund more vital research and care, especially during these unprecedented times. We look forward to having Fiona at the helm of Leukaemia UK to help deliver this mission.”

Fiona Hazell said:

“I’m hugely excited to be joining the Leukaemia UK team as CEO to drive progress for all those affected by leukaemia and other blood cancers – the UK’s third biggest cancer killer. Now more than ever, blood cancer patients and their families across the UK, need new hope for the future and greater support day-to-day and I look forward to collaborating with our incredible supporters and the wider blood cancer community to meet that challenge.”

Fiona begins on 9th September 2020.

Please do not hesitate to contact us on contribute@leukaemiauk.org.uk if you have any questions or queries.

Find out more about our ground-breaking research and care projects.

September is Blood Cancer Awareness Month, find out ways you can get involved.

Related posts

Blood cancer and your emotions – an expert’s insight

9 January 2018

Blood cancer and your emotions – an expert’s insight

Specialist blood cancer counsellor Philip Alexander explains why talking therapies can form a crucial part of treatment

Leukaemia UK bolsters research and advocacy team, in support of ambitious strategy to accelerate progress in the diagnosis, treatment, and care of leukaemia

30 January 2024

Leukaemia UK bolsters research and advocacy team, in support of ambitious strategy to accelerate progress in the diagnosis, treatment, and care of leukaemia

Leukaemia UK is pleased to announce Dr Simon Ridley as the new Director of Research and Advocacy and Dr Georgia Papacleovoulou as the organisation’s first ever Head of Policy and…

Research Blog: A new target for paediatric AML

29 July 2026

Research Blog: A new target for paediatric AML

In May this year one of our Leukaemia UK funded John Goldman Fellows, Dr Noelia Che, published a new paper along with her colleagues: MCL1 inhibition to enhance the efficacy…

Leukaemia UK reveals new strategy to go further than ever to stop leukaemia devastating lives

25 May 2022

Leukaemia UK reveals new strategy to go further than ever to stop leukaemia devastating lives

Leukaemia UK has revealed a new strategy to go further than ever to save and improve more lives, through research, awareness and advocacy.